Skip to content

Author

H. Schunkert

7 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Nov 2026

Abstract 11812: Heterogeneity in Treatment Benefits of Oral Semaglutide in People with Heart Failure with Preserved Ejection Fraction

Importance: Heart failure with preserved ejection fraction (HFpEF) is common among people with visceral adiposity and type 2 diabetes, yet evidence regarding the benefits of oral formulations of semaglutide in clinical practice and the patients most likely to benefit remains limited. Objective: To evaluate the...

N. Krüger, S. Schneeweiss, Yu-Han Kong et al. · 0 citations
Open access Oct 2026

Risk of restenosis for in-stent restenosis and de novo lesions treated during the same percutaneous coronary intervention procedure

Patients undergoing percutaneous coronary intervention (PCI) for in-stent restenosis (ISR) lesions have been reported to experience worse outcomes than those treated for de novo lesions. However, no study has yet directly compared these two lesion types when treated in the same patient during the same procedure....

D. Lahu, S. Lahu, F. Simonetti et al. · 0 citations
Open access Oct 2026

TMEM106B alters vascular smooth muscle cell phenotypes and lysosomal function leading to atherosclerosis

Atherosclerotic cardiovascular diseases (ASCVD), including coronary artery disease (CAD), peripheral artery disease (PAD), and ischemic stroke (IS), account for the majority of global cardiovascular mortality. Although they affect distinct vascular territories, these conditions share overlapping traditional and g...

C. Abrahamian, L. Li, M. Ajayan et al. · 0 citations
Open access Oct 2026

The impact of multiple stent layers on the 10-year outcomes of patients treated with percutaneous coronary intervention for in-stent restenosis

In patients undergoing PCI for ISR, lesions with 2 or more stent layers were associated with a higher risk of recurrent revascularisation than single-layer lesions, however, patients in the multilayer group did not have a higher risk of cardiac death or myocardial infarction.

D. Lahu, T. Koch, V. Schmidt et al. · 0 citations
Open access Oct 2026

Real-world efficacy and tolerability of lipid-lowering therapy in children with monogenic familial hypercholesterolemia in primary care

LLM can be safely and effectively administered in primary care for children with monogenic FH and already low-dose statins resulted in substantial LDL-C reduction, demonstrating real world applicability of guideline recommendations for early start of treatment in FH in a primary care setting.

R. Schmieder, J. Krefting, S. Arens et al. · 0 citations
Open access Oct 2026

Intraindividual longitudinal changes of the proteome reveal dynamic markers of biological aging

Proteomic aging clocks have emerged as biomarkers of aging, but most rely on cross-sectional data. Here, we present a proteomic aging clock based on longitudinal measurements of liquid chromatography–mass spectrometry plasma proteomics at up to three time points in the population-based KORA cohort, comprising 9,105 sam...

R. Lermer, X. Qian, S. Pusch et al. · 0 citations
Review Open access Sep 2026

Percutaneous left atrial appendage occlusion versus oral anticoagulation in patients with atrial fibrillation: a systematic review and meta-analysis.

INTRODUCTION AND OBJECTIVES Percutaneous left atrial appendage occlusion (LAAO) has emerged as an alternative to oral anticoagulants (OACs) in patients with atrial fibrillation (AF). However, up-to-date comparisons are lacking. We performed a systematic review and meta-analysis of randomized clinical trials comparing p...

M. I. Molaro, Cajetan Reichardt, F. Simonetti et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.